290 related articles for article (PubMed ID: 20385753)
21. Cardiolipin Alters
Lin TY; Gross WS; Auer GK; Weibel DB
mBio; 2019 Feb; 10(1):. PubMed ID: 30782656
[TBL] [Abstract][Full Text] [Related]
22. The mode of action of the lantibiotic lacticin 3147--a complex mechanism involving specific interaction of two peptides and the cell wall precursor lipid II.
Wiedemann I; Böttiger T; Bonelli RR; Wiese A; Hagge SO; Gutsmann T; Seydel U; Deegan L; Hill C; Ross P; Sahl HG
Mol Microbiol; 2006 Jul; 61(2):285-96. PubMed ID: 16771847
[TBL] [Abstract][Full Text] [Related]
23. Docking on Lipid II-A Widespread Mechanism for Potent Bactericidal Activities of Antibiotic Peptides.
Grein F; Schneider T; Sahl HG
J Mol Biol; 2019 Aug; 431(18):3520-3530. PubMed ID: 31100388
[TBL] [Abstract][Full Text] [Related]
24. Molecular Dynamics Simulations Reveal the Conformational Flexibility of Lipid II and Its Loose Association with the Defensin Plectasin in the Staphylococcus aureus Membrane.
Witzke S; Petersen M; Carpenter TS; Khalid S
Biochemistry; 2016 Jun; 55(23):3303-14. PubMed ID: 27158738
[TBL] [Abstract][Full Text] [Related]
25. In Vivo Probe of Lipid II-Interacting Proteins.
Sarkar S; Libby EA; Pidgeon SE; Dworkin J; Pires MM
Angew Chem Int Ed Engl; 2016 Jul; 55(29):8401-4. PubMed ID: 27225706
[TBL] [Abstract][Full Text] [Related]
26. Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity.
Wiedemann I; Breukink E; van Kraaij C; Kuipers OP; Bierbaum G; de Kruijff B; Sahl HG
J Biol Chem; 2001 Jan; 276(3):1772-9. PubMed ID: 11038353
[TBL] [Abstract][Full Text] [Related]
27. Structural insights into inhibition of lipid I production in bacterial cell wall synthesis.
Chung BC; Mashalidis EH; Tanino T; Kim M; Matsuda A; Hong J; Ichikawa S; Lee SY
Nature; 2016 May; 533(7604):557-560. PubMed ID: 27088606
[TBL] [Abstract][Full Text] [Related]
28. Comparative Analysis of the Antimicrobial Activities of Plant Defensin-Like and Ultrashort Peptides against Food-Spoiling Bacteria.
Kraszewska J; Beckett MC; James TC; Bond U
Appl Environ Microbiol; 2016 Jul; 82(14):4288-4298. PubMed ID: 27208129
[TBL] [Abstract][Full Text] [Related]
29. An oldie but a goodie - cell wall biosynthesis as antibiotic target pathway.
Schneider T; Sahl HG
Int J Med Microbiol; 2010 Feb; 300(2-3):161-9. PubMed ID: 20005776
[TBL] [Abstract][Full Text] [Related]
30. Identification and Biological Characterization of Mouse beta-defensin 14, the orthologue of human beta-defensin 3.
Röhrl J; Yang D; Oppenheim JJ; Hehlgans T
J Biol Chem; 2008 Feb; 283(9):5414-9. PubMed ID: 18167348
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of peptidoglycan biosynthesis in gram-positive bacteria by LY146032.
Allen NE; Hobbs JN; Alborn WE
Antimicrob Agents Chemother; 1987 Jul; 31(7):1093-9. PubMed ID: 2821889
[TBL] [Abstract][Full Text] [Related]
32. Identification of a cell-penetrating peptide domain from human beta-defensin 3 and characterization of its anti-inflammatory activity.
Lee JY; Suh JS; Kim JM; Kim JH; Park HJ; Park YJ; Chung CP
Int J Nanomedicine; 2015; 10():5423-34. PubMed ID: 26347021
[TBL] [Abstract][Full Text] [Related]
33. Engineering and characterization of human β-defensin-3 and its analogues and microcin J25 peptides against Mannheimia haemolytica and bovine neutrophils.
Dhingra H; Kaur K; Singh B
Vet Res; 2021 Jun; 52(1):83. PubMed ID: 34112244
[TBL] [Abstract][Full Text] [Related]
34. Differential inhibition of Staphylococcus aureus PBP2 by glycopeptide antibiotics.
Leimkuhler C; Chen L; Barrett D; Panzone G; Sun B; Falcone B; Oberthür M; Donadio S; Walker S; Kahne D
J Am Chem Soc; 2005 Mar; 127(10):3250-1. PubMed ID: 15755121
[TBL] [Abstract][Full Text] [Related]
35. Targeting bactoprenol-coupled cell envelope precursors.
Ulm H; Schneider T
Appl Microbiol Biotechnol; 2016 Sep; 100(18):7815-25. PubMed ID: 27495122
[TBL] [Abstract][Full Text] [Related]
36. The innate defense antimicrobial peptides hBD3 and RNase7 are induced in human umbilical vein endothelial cells by classical inflammatory cytokines but not Th17 cytokines.
Burgey C; Kern WV; Römer W; Sakinc T; Rieg S
Microbes Infect; 2015 May; 17(5):353-9. PubMed ID: 25637949
[TBL] [Abstract][Full Text] [Related]
37. The β-lactamase gene regulator AmpR is a tetramer that recognizes and binds the D-Ala-D-Ala motif of its repressor UDP-N-acetylmuramic acid (MurNAc)-pentapeptide.
Vadlamani G; Thomas MD; Patel TR; Donald LJ; Reeve TM; Stetefeld J; Standing KG; Vocadlo DJ; Mark BL
J Biol Chem; 2015 Jan; 290(5):2630-43. PubMed ID: 25480792
[TBL] [Abstract][Full Text] [Related]
38. Anchoring of surface proteins to the cell wall of Staphylococcus aureus. III. Lipid II is an in vivo peptidoglycan substrate for sortase-catalyzed surface protein anchoring.
Perry AM; Ton-That H; Mazmanian SK; Schneewind O
J Biol Chem; 2002 May; 277(18):16241-8. PubMed ID: 11856734
[TBL] [Abstract][Full Text] [Related]
39. Capillary zone electrophoresis assay of the uridine diphosphate N-acetylmuramyl peptide precursors and the disaccharide pentapeptide derivative of bacterial cell wall peptidoglycan.
Richards RM; Xing DK
J Pharm Biomed Anal; 1994 Mar; 12(3):301-5. PubMed ID: 8031928
[TBL] [Abstract][Full Text] [Related]
40. The lipopeptide antibiotic Friulimicin B inhibits cell wall biosynthesis through complex formation with bactoprenol phosphate.
Schneider T; Gries K; Josten M; Wiedemann I; Pelzer S; Labischinski H; Sahl HG
Antimicrob Agents Chemother; 2009 Apr; 53(4):1610-8. PubMed ID: 19164139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
